232 related articles for article (PubMed ID: 38645568)
1. Sustained release local anesthetics for pain management: relevance and formulation approaches.
Getachew M; Tesfaye H; Yihunie W; Ayenew T; Alemu S; Dagnew EM; Biyazin Y; Abebe D; Degefu N; Abebaw A
Front Pain Res (Lausanne); 2024; 5():1383461. PubMed ID: 38645568
[TBL] [Abstract][Full Text] [Related]
2. Evolving Role of Local Anesthetics in Managing Postsurgical Analgesia.
Golembiewski J; Dasta J
Clin Ther; 2015 Jun; 37(6):1354-71. PubMed ID: 25866297
[TBL] [Abstract][Full Text] [Related]
3. Recent Research Advances in Nano-Based Drug Delivery Systems for Local Anesthetics.
Ma H; Pan Z; Lai B; Zan C; Liu H
Drug Des Devel Ther; 2023; 17():2639-2655. PubMed ID: 37667787
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of ondansetron as an adjunct to lidocaine intravenous regional anesthesia on tourniquet pain and postoperative pain in patients undergoing elective hand surgery: a systematic review protocol.
Badeaux J; Bonanno L; Au H
JBI Database System Rev Implement Rep; 2015 Jan; 13(1):27-38. PubMed ID: 26447005
[TBL] [Abstract][Full Text] [Related]
5. Development of an effective topical liposomal formulation for localized analgesia and anti-inflammatory actions in the Complete Freund's Adjuvant rodent model of acute inflammatory pain.
Iwaszkiewicz KS; Hua S
Pain Physician; 2014; 17(6):E719-35. PubMed ID: 25415787
[TBL] [Abstract][Full Text] [Related]
6. Liposomal bupivacaine and novel local anesthetic formulations.
Prabhakar A; Ward CT; Watson M; Sanford J; Fiza B; Moll V; Kaye RJ; Morgan Hall O; Cornett EM; Urman RD; Kaye AD
Best Pract Res Clin Anaesthesiol; 2019 Dec; 33(4):425-432. PubMed ID: 31791561
[TBL] [Abstract][Full Text] [Related]
7. Liposomal bupivacaine infiltration at the surgical site for the management of postoperative pain.
Hamilton TW; Athanassoglou V; Mellon S; Strickland LH; Trivella M; Murray D; Pandit HG
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD011419. PubMed ID: 28146271
[TBL] [Abstract][Full Text] [Related]
8. Injectable nanocomposite analgesic delivery system for musculoskeletal pain management.
Khanal M; Gohil SV; Kuyinu E; Kan HM; Knight BE; Baumbauer KM; Lo KW; Walker J; Laurencin CT; Nair LS
Acta Biomater; 2018 Jul; 74():280-290. PubMed ID: 29803784
[TBL] [Abstract][Full Text] [Related]
9. In search of the Holy Grail: Poisons and extended release local anesthetics.
Coppens SJR; Zawodny Z; Dewinter G; Neyrinck A; Balocco AL; Rex S
Best Pract Res Clin Anaesthesiol; 2019 Mar; 33(1):3-21. PubMed ID: 31272651
[TBL] [Abstract][Full Text] [Related]
10. Prolonged analgesia with liposomal bupivacaine in a mouse model.
Grant GJ; Vermeulen K; Langerman L; Zakowski M; Turndorf H
Reg Anesth; 1994; 19(4):264-9. PubMed ID: 7947427
[TBL] [Abstract][Full Text] [Related]
11. Local Anesthetics, Local Anesthetic Systemic Toxicity (LAST), and Liposomal Bupivacaine.
On'Gele MO; Weintraub S; Qi V; Kim J
Clin Sports Med; 2022 Apr; 41(2):303-315. PubMed ID: 35300842
[TBL] [Abstract][Full Text] [Related]
12. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
13. New formulations of bupivacaine for the treatment of postoperative pain: liposomal bupivacaine and SABER-Bupivacaine.
Skolnik A; Gan TJ
Expert Opin Pharmacother; 2014 Aug; 15(11):1535-42. PubMed ID: 24992382
[TBL] [Abstract][Full Text] [Related]
14. [Liposomal bupivacaine-No breakthrough in postoperative pain management].
Otremba B; Dinges HC; Schubert AK; Zink W; Steinfeldt T; Wulf H; Wiesmann T
Anaesthesiologie; 2022 Jul; 71(7):556-564. PubMed ID: 35469071
[TBL] [Abstract][Full Text] [Related]
15. Epidural sustained release ropivacaine prolongs anti-allodynia and anti-hyperalgesia in developing and established neuropathic pain.
Li TF; Fan H; Wang YX
PLoS One; 2015; 10(1):e0117321. PubMed ID: 25617901
[TBL] [Abstract][Full Text] [Related]
16. Local infiltration of HYR-PB21, a sustained-release formulation of bupivacaine, provides analgesia and reduces opioid requirement after haemorrhoidectomy: a randomised controlled trial.
Cui J; Xu Q; Yu Z; Sun J; Zheng Y; Huang W; Yu Y; Gao S; Wang Z; Zhang S
Br J Anaesth; 2022 Dec; 129(6):970-976. PubMed ID: 36243580
[TBL] [Abstract][Full Text] [Related]
17. Patterns of Immediate-Release and Extended-Release Opioid Analgesic Use in the Management of Chronic Pain, 2003-2014.
Hwang CS; Kang EM; Ding Y; Ocran-Appiah J; McAninch JK; Staffa JA; Kornegay CJ; Meyer TE
JAMA Netw Open; 2018 Jun; 1(2):e180216. PubMed ID: 30646061
[TBL] [Abstract][Full Text] [Related]
18. A Randomized, Multicenter, Double-Blind Study of Local Infiltration Analgesia with Liposomal Bupivacaine for Postsurgical Pain Following Total Knee Arthroplasty: Rationale and Design of the Pillar Trial.
Dysart S; Snyder MA; Mont MA
Surg Technol Int; 2016 Nov; 30():261-267. PubMed ID: 27824434
[TBL] [Abstract][Full Text] [Related]
19. New modalities of pain treatment after outpatient orthopaedic surgery.
Beaussier M; Sciard D; Sautet A
Orthop Traumatol Surg Res; 2016 Feb; 102(1 Suppl):S121-4. PubMed ID: 26803223
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
